GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Ending Cash Position

Longevity Biomedical (Longevity Biomedical) Ending Cash Position : $0.00 Mil (As of . 20)


View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical Ending Cash Position?

Longevity Biomedical's Ending Cash Position for the quarter that ended in . 20 was $0.00 Mil.

Longevity Biomedical Ending Cash Position Historical Data

The historical data trend for Longevity Biomedical's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical Ending Cash Position Chart

Longevity Biomedical Annual Data
Trend
Ending Cash Position

Longevity Biomedical Semi-Annual Data
Ending Cash Position

Longevity Biomedical Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Longevity Biomedical's Ending Cash Position for the fiscal year that ended in . 20 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=+
=0.00

Longevity Biomedical's Ending Cash Position for the quarter that ended in . 20 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=+
=0.00

Longevity Biomedical Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Longevity Biomedical (Longevity Biomedical) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Ending Cash Position
Comparable Companies
Traded in Other Exchanges
N/A
Address
12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Website
https://www.longevitybiomedical.com
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines